The GSEA assay in the study revealed that the Sox2-targeted gene set was enriched in poorly differentiated tumors, and that Sox2 expression was correlated with tumor differentiation, grade and recurrence in CRC specimens. The gene discussed is SOX2; the disease is colorectal carcinoma.